Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Anticancer Research|December 25, 2009
Radioimmunotherapy of heavily pre-treated, non-Hodgkin's lymphoma patients: efficacy and safety in a routine settingFrancesco Cicone, Rossella Baldini, Maria Christina Cox, et al.
Endocrine|September 13, 2014
Thyro-gastric autoimmunity in patients with differentiated thyroid cancer: a prospective studyFrancesco Cicone, Annalisa Papa, Chiara Lauri, et al.
Journal of Psychoactive Drugs|February 12, 2019
Dorsolateral Prefrontal Cortex Impairment in Methoxetamine-Induced Psychosis: An <sup>18</sup>F-FDG PET/CT Case StudyLorenzo Moccia, Anna Tofani, Marianna Mazza, et al.
Cancers|June 10, 2023
Predictive Role of Serum Thyroglobulin after Surgery and before Radioactive Iodine Therapy in Patients with Thyroid CarcinomaAlberto Signore, Chiara Lauri, Arianna Di Paolo, et al.
Neurological Research|December 9, 2008
Central and peripheral dopamine transporter reduction in Parkinson's diseaseFrancesca R Buttarelli, Gabriela Capriotti, Clelia Pellicano, et al.
Neuro-Oncology|October 23, 2020
Long-term metabolic evolution of brain metastases with suspected radiation necrosis following stereotactic radiosurgery: longitudinal assessment by F-DOPA PETFrancesco Cicone, Luciano Carideo, Claudia Scaringi, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 27, 2008
High-resolution, hand-held camera for sentinel-node detectionFrancesco Scopinaro, Anna Tofani, Gianpaolo di Santo, et al.
Pituitary|January 20, 2009
Efficacy of the combined cabergoline and octreotide treatment in a case of a dopamine-agonist resistant macroprolactinomaAlessandra Fusco, Francesca Lugli, Eugenia Sacco, et al.
Pituitary|December 31, 2011
Treatment with octreotide LAR in clinically non-functioning pituitary adenoma: results from a case-control studyAlessandra Fusco, Antonella Giampietro, Antonio Bianchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2022
Analysis of Short-Term and Stable DNA Damage in Patients with Differentiated Thyroid Cancer Treated with <sup>131</sup>I in Hypothyroidism or with Recombinant Human Thyroid-Stimulating Hormone for Remnant AblationAlberto Signore, Giuseppe Campagna, Jessica Marinaccio, et al.
Pageof 1